Contact
Privacy Policy

Copyright © DEEPNOID Inc. All rights reserved.

Back to list
Medical AI

DEEPNOID Partners with HealthHub on an AI Pilot Project in Indonesia, Integrating Its Generative AI-Based M4CXR and Conducting Clinical Validation

October 22, 2025
DEEPNOID Partners with HealthHub on an AI Pilot Project in Indonesia, Integrating Its Generative AI-Based M4CXR and Conducting Clinical Validation

Integrating M4CXR with HealthHub’s PACS to validate local system efficiency and data interoperability
“We will explore the potential to expand AI-based telemedicine models globally through research and validation based on local patient data in Indonesia”

DEEPNOID, one of Korea’s first-generation medical AI companies (CEO Woo Sik Choi), announced that it will collaborate with HealthHub (CEO Wonho Song) on a tuberculosis (TB) AI pilot project in Indonesia.
Led by HealthHub and its Indonesian subsidiary, PT TCI, the collaboration will integrate a teleradiology platform with AI interpretation technology, and validate it through clinical use. HealthHub will provide its teleradiology system and operating infrastructure. DEEPNOID will support the technical integration of M4CXR, its generative AI-based interpretation support solution for chest X-ray, and provide software for the pilot.
The pilot is a research and validation project that aims to assess the local applicability of AI interpretation technology, verify system efficiency, and ensure data interoperability. The two companies are integrating HealthHub’s picture archiving and communication system (PACS) with DEEPNOID’s M4CXR, and will then carry out the pilot project in Indonesia in phases.
The project began in Jakarta, Indonesia, on October 20, 2025. Using chest X-ray images collected at Dr. Soeharto Heerdjan Hospital (RS Soeharto Heerdjan), a hospital under Indonesia’s Ministry of Health (Kemenkes), local clinicians will refer to AI-generated draft reports produced by M4CXR when making diagnoses.
M4CXR is an AI-based digital medical device developed by DEEPNOID that detects 41+ findings on chest X-ray images and automatically generates AI-generated draft reports. As of October 2025, M4CXR was undergoing a multicenter, retrospective, confirmatory clinical trial approved by Korea’s Ministry of Food and Drug Safety (MFDS) in August 2025.
HealthHub is a cloud-based teleradiology platform company. It has built teleradiology infrastructure in major Southeast Asian countries, including Indonesia and Vietnam, and operates a platform that connects local medical institutions with radiologists.
“By combining HealthHub’s cloud-based teleradiology platform with DEEPNOID’s AI interpretation technology, we can deliver innovative solutions to regions with limited access to healthcare,” said Wonho Song, CEO of HealthHub. “Through this collaboration, we will validate the technological synergy between our two companies and lay the foundation for expanding AI-based telemedicine models not only in Korea but also in global markets.”
“This collaboration is designed to build global clinical validation experience for M4CXR, our core solution, and to verify its technical reliability and data suitability,” said Woo Sik Choi, CEO of DEEPNOID. “Through integration with HealthHub’s teleradiology platform, we will explore AI collaboration models that can be applied to the healthcare systems of various countries.”

###